Cases & Deals

Antigenics develops patent portfolio for cancer and infectious disease therapies

Clients Antigenics, Inc.

Jones Day represented Antigenics, Inc. in the development of its patent portfolio and prosecution strategy relating to immunotherapy for cancer and infectious disease, and cancer chemotherapeutics including Oncophage® vaccine technology. This work includes counseling and participation in reexaminations and European oppositions.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.